Email

mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIRgov>; NIAID DCR-OCGR il.nih.gov>; Nealy, Michael (NIH/NIAID) [E] nih.gov>; Harper, Jill (NIH/NIAID) [E] h.gov>; Parker, Marie (NIH/NIAID) [E] niaid.nih.gov>; Read, Sarah (NIH/NIAID) [E] niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E] nih.gov> Cc: NIAID OCGR Leg 'mi .gov>; Erbelding, Emily (NIH/NIAID) [E] io Holland, Steven ( gov>; Hanson, Christopher (NIH/NIAID) [E] niaid.nih.gov>; Poe, Kelly (NIH/NIAID) [E] ov>; Gilles, Sharon (NIH/NIAID) [E] I .gov>; DDSM Correspondences (et ates arn Subject: ACTION by 10a Thurs (10/17): Review compiled HHS comments on revised bill text for Risky Research Review Act nih.gov>; 3; ients y (10/17), please provide any M [AID DEA DART ID DIR-OCGR < ID DCR-OCGR ay i] NIAID) (NIH/NIAID) [E] [E] J 4/NIAID) [E] VIH/NIAID) [I] iy >; (NIH/NIAID) [E] IIH/NIAID) [--] NIAID) [E] > edon the 3 time. Good Afternoon, NIAID has been asked to review the attached compiled HHS comments on S.4667 (Risky Research Review Act), as amended. OSP, OER, and ORS also are reviewing. As you may recall, NIAID previously provided NIH OD with comments on the revised bill text, which are attached for your reference, as well as high-level bullets (see email chain below). ACTION: By 10a Thursday (10/17), please provide any new edits/comments in the attached "HHS points" document. Please let us know if you have any questions. Thanks, Chase